Horizons Virtual 2020 registration is now open! This annual international higher education event has gone virtual this year, which means that on 6 October at 10:30 a.m. BST, you can attend with a beverage in-hand while connecting and learning with a global audience.

Horizons has become a mainstay to gather thought leaders, experts, and technologists in the education sector, becoming one of the industry’s annual events in Europe. Thus, whether you’re a repeat attendee or new to the scene, we want you in the virtual room with us this year.

So with Horizons going virtual for 2020, what exactly can you expect? Here are the top three reasons to attend Horizons virtual:

  1. A phenomenal keynote session featuring a top European business school and their never-before-seen Education Cloud success story.
  2. Global perspectives! International is at the heart of our agenda for Horizons 2020. Hear from university leaders in the U.K., U.S.,
Read more

Warren Buffett is a renowned American billionaire and one of the most successful investors in the world. He is often reffered to as ‘the Oracle of Omaha‘. He was the favourite student of Benjamin Graham, the father of value investing. In plain terms, Graham’s method involves spotting good, undervalued companies, buying them, and holding them forever.

What do I mean by ‘good‘ companies? Well, most importantly, they have to be profitable. This doesn’t just mean having high net profit margins. It also means a company should have a good track record of rising profits. Of course, this doesn’t guarantee the firm’s profitability will keep rising in the future. But at least it makes investing in such a company somewhat safer. Of course, dividend-paying companies have a big advantage over their peers that don’t pay dividends.

Then, a great business should also have a sound financial … Read more

Snowflake (NYSE: SNOW) shares were listed on the New York Stock Exchange this week. On its first day of trading, the share price popped higher to more than double. The cloud data warehousing firm had the largest software initial public offering (IPO) on record, valuing it at around $70bn – more than five times the private market valuation it reached in February.

Snowflake shares were priced at $120, after being revised higher twice this month. On the first day of trading, the share price climbed to over $300, and finished the day up 112% at $255.

Early investors of Snowflake shares include Salesforce and Berkshire Hathaway. The investment by the conglomerate run by Warren Buffett is interesting. Buffett rarely gets interested in technology startups that are not yet profitable, and tends to opt for more mature companies.

Snowflake’s IPO comes at a similar time to several technology IPOs. It … Read more

Nonprofit and education organizations alike have had their work cut out for them this year. With so many challenges hitting so quickly, it can feel like a non-stop effort just to stay in place. So first, let me say this: Thank you, to our nonprofit and our education customers. We see you on the front lines, working tirelessly in a time when nothing is certain. It’s because the work you do is so important that the public is as invested in keeping your mission going as you are.

In a post-pandemic world, donor trust is paramount.

Donors are always evaluating where their donations can make the most impact. In the landscape of COVID-19, the trust between an organization and its donors has become more important than ever. Donor trust has always been mission-critical, but in today’s rapidly shifting environment it has become mission-imperative. So how can you earn … Read more

The demand for pharmaceutical companies’ stocks has surged dramatically. AstraZeneca (LSE:AZN) shares have been no exception. Investor enthusiasm was fuelled by hopes of a new Covid-19 vaccine. But isn’t the AstraZeneca share price already too high? 

Why did the AstraZeneca share price rally?

On Monday, the pharma giant resumed phase 3 vaccine trials. As we all know, the company’s stock has been surging in recent months. That’s because people expect AstraZeneca to develop a Covid-19 vaccine. But is the future so bright for AstraZeneca and its vaccine?

Quite recently the FDA said AstraZeneca’s coronavirus vaccine trial in the US is still pending. That’s because the FDA is unsure if there is a big safety issue or not. So, many questions remain. Phase 3 vaccine trials don’t mean the vaccine will be available tomorrow. What’s more, the FDA’s investigation also suggests there are still many regulatory hurdles. That’s why the AstraZeneca … Read more